Armenia / Fierce Biotech
2.
Headlines and brief publisher-provided excerpts about 2, with links to the original reports.
Publisher coverage
From Fierce Biotech.
REPORT / 012026-10-29T18:09:59.000Z
Eli Lilly scraps phase 2 Alzheimer's program after drug falls short of expectations
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPMi1zQUd4ZWF4czhpWDRvdDQydWtoWFlKNTJ4dzdpcm9uNHA5VGR1OE42VWxyYXhPVE85V3FveU03eWdIeTNJWHN3OV9xVjd1TmZ6Rmx4QlhmWHpUYVR2R0Q1d0FZNFBPM2lWRlBuV1EtU0kwVUFqdkV0ZGp0RTAyVUU0RVBkaTZ1NEF4a1o2X2l0TklaQ3BxNWZucWs1SnIzOWdJakxMTVdnY1NvRzFXcGRTOA?oc=5" target="_blank">Eli Lilly scraps phase 2 Alzheimer's program after drug falls short of expectations</
Read the original report